Pritesh Shah
Geen lopende functies
Vermogen: 2 M $ op 31-03-2024
Profiel
Pritesh Shah worked as a Marketing Director for the Oncology Pipeline at OSI Pharmaceuticals, Inc. He then worked as the Chief Growth Officer at NovoCure Ltd.
from 2022 to 2024.
Prior to his work experience, he earned a graduate degree from Seton Hall University and a doctorate from the University of Maryland.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NOVOCURE LTD.
0.12% | 07-11-2023 | 124 511 ( 0.12% ) | 2 M $ | 31-03-2024 |
Eerdere bekende functies van Pritesh Shah
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVOCURE LIMITED | Corporate Officer/Principal | 01-01-2024 |
| OSI PHARMACEUTICALS, INC. | Sales & Marketing | - |
Opleiding van Pritesh Shah
| Seton Hall University | Graduate Degree |
| University of Maryland | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NOVOCURE LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
